NASDAQ: AIDX
20/20 Biolabs Inc Stock Ownership - Who owns 20/20 Biolabs?

Insider buying vs selling

Have 20/20 Biolabs Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when AIDX insiders and whales buy or sell their stock.

AIDX Shareholders

What type of owners hold 20/20 Biolabs Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jonathan M. Cohen12.88%1,366,400$799.34kInsider
Cresset Asset Management LLC2.49%264,368$154.66kInstitution
Citadel Advisors LLC0.15%16,227$9.49kInstitution
John G. Compton0.14%14,335$8.39kInsider
John Woodson Rollins0.10%11,111$6.50kInsider
Xtx Topco Ltd0.10%10,329$6.04kInstitution
Ubs Group Ag0.08%8,314$4.86kInstitution
Richard M. Cohen0.07%7,700$4.50kInsider
Mai Capital Management0.01%1,000$585.00Institution
Toth Financial Advisory Corp0.00%157$91.85Institution

1 of 2

AIDX vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AIDX2.83%13.19%
XAIR9.59%90.41%Net Buying
VVOS13.12%65.46%Net Buying
ITOC0.57%45.17%
INBS8.71%68.25%

20/20 Biolabs Stock Ownership FAQ

Who owns 20/20 Biolabs?

20/20 Biolabs (NASDAQ: AIDX) is owned by 2.83% institutional shareholders, 13.19% 20/20 Biolabs insiders, and 83.98% retail investors. Jonathan M. Cohen is the largest individual 20/20 Biolabs shareholder, owning 1.37M shares representing 12.88% of the company. Jonathan M. Cohen's 20/20 Biolabs shares are currently valued at $789.78k.

If you're new to stock investing, here's how to buy 20/20 Biolabs stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.